Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zentera Therapeutics

Request full access

Clinical-stage oncology therapeutics for the Chinese market

ChinaFounded 2020Biotech & Life Sciences

About Zentera Therapeutics

Zentera Therapeutics is a clinical-stage biopharmaceutical company headquartered in Shanghai, China, that focuses on developing and commercializing oncology treatments. The company was established in May 2020 as a joint venture by its US-based parent company, Zentalis Pharmaceuticals, to bring cancer therapies to the Chinese market. Dr. Anthony Sun, the CEO of Zentalis, also serves as the CEO of Zentera. The formation was initiated with a $20 million Series A financing led by Tybourne Capital Management and OrbiMed Asia. This was followed by a $75 million Series B financing in August 2021 to further advance clinical development.

The company's business model is centered on licensing and developing a pipeline of oncology candidates discovered by Zentalis specifically for the Greater China market. Zentera has operations in Shanghai and Beijing and aims to become a leading biopharmaceutical firm in China. Its pipeline includes small molecule therapeutics targeting fundamental biological pathways in cancers. Key product candidates under development include Azenosertib (ZN-c3), a WEE1 inhibitor for solid tumors; ZN-c5, an oral Selective Estrogen Receptor Degrader (SERD) for ER+/HER2- breast cancer; and Asaretoclax (ZN-d5), a BCL-2 inhibitor for hematologic malignancies. The company strategy involves participating in global clinical trials with Zentalis and potentially in-licensing additional oncology assets for development. Recently, Zentalis announced the discontinuation of the development of ZN-d5 in combination with azenosertib.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Dealroom signal
59.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Aug 2021 $75M $300M Farallon Capital Management · Viking Global Investors · Redmile Group · Perceptive Advisors —
SERIES AOther financing May 2020 $20M $80M Tybourne Capital Management · OrbiMed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Zentera Therapeutics website traffic

Latest recorded traffic for Zentera Therapeutics is 250 monthly website visits. Zentera Therapeutics's team grew 0% over the past year.

Latest monthly visits250 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Zentera Therapeutics in its local ecosystem

Live from Dealroom

The Zentera Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A11 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zentera Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zentera Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.